Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

BTK Inhibitors Important in the Treatment Landscape of MCL

Michael Wang, MD, The University of Texas MD Anderson Cancer Center, Houston, discusses the importance of Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of patients with mantle cell lymphoma (MCL).

 

Advertisement

Advertisement

Advertisement

Advertisement